Fig. 5From: N-glycosylation of serum proteins for the assessment of patients with IgD multiple myelomaThe differential diagnostic performance of N-glycan biomarkers in IgD MM. a The abundance of NA2FB/NG1(3)A2F (peak 7/peak 4) was significantly increased in patients with IgD MM compared with those with LCMM. b The ROC curve demonstrated the ability of the serum NA2FB/NG1(3)A2F levels to differentially diagnose IgD MM from LCMMBack to article page